Retrospective analysis of factors influencing the development and progression of hepatic encephalopathy in patients with hepatitis B virusrelated cirrhosis

World Chinese Journal of Digestology

Volumn 20, Issue 13, 2012, Pages 1148-1155

  Zhang, Ming ^a,b   Duan, Zhi Jun ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Blood ammonia; Hepatic encephalopathy; Hepatitis B cirrhosis; Precipitating factors

Indexed keywords

ALBUMIN; AMMONIA; BILIRUBIN; CHOLINESTERASE; CREATININE; SODIUM;

AGE; ARTICLE; ASCITES; CHILD PUGH SCORE; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS VARICES; GENDER; HEPATIC ENCEPHALOPATHY; HEPATITIS B VIRUS; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SPLENOMEGALY; UREA NITROGEN BLOOD LEVEL;

EID: 84922686110     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
2. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61: 362-366
3. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17: 1730-1733
4. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-496
5. Chinise sourse
6. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001; 33: 473-475
7. Rohra DK, Jaipal AA, Mahmood K, Ahuja KL. Precipitating factors of hepatic encephalopathy in patients with chronic liver disease at Civil Hospital Karachi. J Coll Physicians Surg Pak 2008; 18: 130-131
8. Devrajani BR, Shah SZ, Devrajani T, Kumar D. Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad. J Pak Med Assoc 2009; 59: 683-686
9. Benhaddouch Z, Abidi K, Naoufel M, Abouqal R, Zeggwagh AA. [Mortality and prognostic factors of the cirrhotic patients with hepatic encephalopathy admitted to medical intensive care unit]. Ann Fr Anesth Reanim 2007; 26: 490-495
10. Chinise sourse
11. Shawcross DL, Olde Damink SW, Butterworth RF, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis 2005; 20: 169-179
12. Iacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009; 37: S331-S336
13. Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010; 51: 1062-1069
14. Butterworth RF. Pathophysiology of hepatic encephalopathy: The concept of synergism. Hepatol Res 2008; 38: S116-S121
15. Arias JL, Aller MA, Sánchez-Patan F, Arias J. The inflammatory bases of hepatic encephalopathy. Eur J Gastroenterol Hepatol 2006; 18: 1297-1310
16. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol 2009; 28: 5-16
17. Bo ZJ, Qiu DK, Ma X, Zhang GS, Fan ZP, Huang YQ, Yu XF, Zeng MD. [Assessment of the healthrelated quality of life of patients with minimal hepatic encephalopathy]. Zhonghua Ganzangbing Zazhi 2007; 15: 412-416
18. Omagari K, Ohba K, Kadokawa Y, Hazama H, Masuda J, Kinoshita H, Matsuo I, Ohnita K, Mizuta Y, Hayashida K, Kohno S. Comparison of the grade evaluated by "Liver damage" of Liver Cancer Study Group of Japan and Child-Pugh classification in patients with hepatocellular carcinoma. Hepatol Res 2006; 34: 266-272
19. Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004; 2: 157-163
20. Hillaire S, Voitot H. [Cirrhosis]. Pathol Biol (Paris) 1999; 47: 895-902
21. Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34: 46-52
22. Magliocchetti N, Torchio P, Corrao G, Aricò S, Favilli S. Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation. Ital J Gastroenterol Hepatol 1997; 29: 38-46
23. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723
24. Kim DU, Park GT, Koh DH, Cho HS, Kim YH, Shim SG, Kim JB, Lee SH, Choi HS, Hahm JS, Lee MH. [Five-year follow-up of clinical and laboratory data of early liver cirrhosis patients confirmed by liver biopsy]. Taehan Kan Hakhoe Chi 2002; 8: 256-263
25. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-2034
26. Takikawa Y, Endo R, Suzuki K, Tsubouchi H. Early prediction of short-term development of hepatic encephalopathy in patients with acute liver disease unrelated to paracetamol. A prospective study in Japan. J Hepatol 2009; 51: 1021-1029
27. Jang JW. Current status of liver diseases in Korea: liver cirrhosis. Korean J Hepatol 2009; 15 Suppl 6: S40-S49
28. Ackermann D. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis]. Ther Umsch 2009; 66: 747-751
29. Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008; 57: 1156-1165
30. Shaikh S, Mal G, Khalid S, Baloch GH, Akbar Y. Frequency of hyponatraemia and its influence on liver cirrhosis-related complications. J Pak Med Assoc 2010; 60: 116-120
31. Kim JH, Lee JS, Lee SH, Bae WK, Kim NH, Kim KA, Moon YS. The association between the serum sodium level and the severity of complications in liver cirrhosis. Korean J Intern Med 2009; 24: 106-112
32. Angeli P, Wong F, Watson H, Ginès P. Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 2006; 44: 1535-1542
33. Kim SU, Han KH, Nam CM, Park JY, Kim do Y, Chon CY, Ahn SH. Natural history of hepatitis B vi rus-related cirrhotic patients hospitalized to control ascites. J Gastroenterol Hepatol 2008; 23: 1722-1727
34. Jenq CC, Tsai MH, Tian YC, Chang MY, Lin CY, Lien JM, Chen YC, Fang JT, Chen PC, Yang CW. Serum sodium predicts prognosis in critically ill cirrhotic patients. J Clin Gastroenterol 2010; 44: 220-226
35. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890-895
36. Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999; 170: 138-146
37. Chinise sourse
38. Mathurin S, Jaimet C, Turletti C, Arosio A, González G, Kuzmicz G. [Renal failure in patients with cirrhosis and ascites: incidence, etiology and predictive factors]. Acta Gastroenterol Latinoam 2008; 38: 116-125
39. He Y, Li GX, Xia Y. [Analysis of the relationship between hepatorenal syndrome and plasma ammonia]. Zhonghua Ganzangbing Zazhi 2010; 18: 45-48